Duloxetine: urinary incontinence and marketing authorization incontinence
نویسندگان
چکیده
منابع مشابه
How to Check Urinary Incontinence
دیواره مثانه شامل شبکه انبوهی از فیبرهای عضلانی صاف می باشد که از افزایش ناگهانی فشار مثانه که منجر به انقباض و نشت ادرار از مثانه قبل از پرشدن کامل آن می شود جلوگیری می کند و حدود ۵۰۰ سی سی ادرار را در خود جای می دهد. مجرای پیشابراه که بعنوان محل خروجی برای مثانه محسوب می شود شامل دو لایه عضله صاف و یک ناحیه تنگ شده عضلانی است که تحت کنترل ارادی می باشد و بعنوان اسفنکتر خارجی عمل می کند. هنگام...
متن کاملACUPUNCTURE AND URINARY INCONTINENCE About URINARY INCONTINENCE
Around 1.5% of adults in Europe and the USA have urge urinary incontinence (involuntary leakage immediately preceded or accompanied by urgency) (Abrams 2003; Irwin 2006). This is usually due to overactive bladder syndrome (defined as urgency, with or without urge incontinence, and usually with frequency and nocturia) (Abrams 2003). The symptoms of an overactive bladder are thought to be due to ...
متن کاملACUPUNCTURE AND URINARY INCONTINENCE About urinary incontinence
Around 1.5% of adults in Europe and the USA have urge urinary incontinence (involuntary leakage immediately preceded or accompanied by urgency) (Abrams 2003; Irwin 2006). This is usually due to overactive bladder syndrome (defined as urgency, with or without urge incontinence, and usually with frequency and nocturia) (Abrams 2003). The symptoms of an overactive bladder are thought to be due to ...
متن کاملDuloxetine in the treatment of stress urinary incontinence
This manuscript reviews the pharmacodynamics and pharmacokinetics of duloxetine and its efficacy and safety in women with stress urinary incontinence. Duloxetine is a selective inhibitor of neuronal serotonin and norepinephrine uptake which increases urethral striated muscle activity and bladder capacity. Duloxetine is readily absorbed and extensively metabolized; cytochrome P450 1A2 (CYP1A2) i...
متن کاملUpdate on duloxetine for the management of stress urinary incontinence
Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely proven efficacy to have been licensed for the medical treatment of women with stress urinary incontinence (SUI). Despite favorable results from randomized controlled trials, surgical management continues to be the mainstay of treatment for SUI. In this review we explore...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2017
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.732561